Delivery Order SPE2DB22D2005-SPE2DB25FJNX3
Award Date
6/23/25
Potential Completion Date
6/24/25
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,855.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a medical product, with an ultimate completion date of April 18, 2025. The contract is a Firm Fixed Price Delivery Order, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RABAVERT RABIES VACC W-DILUENTS, a vaccine product, with a ceiling value of $10,479.00 and a period of performance through May 19, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $6,287.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a vaccine product, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a rabies vaccine product, with a ceiling value of $2,514.96 and a completion date of May 20, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. The contract will be performed in Conshohocken, Pennsylvania....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a total ceiling value of $17,123.97 and a performance period through May 2, 2025. It is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,479.00 firm-fixed-price delivery order is for the provision of RABAVERT RABIES VACC W-DILUENTS, with a completion date of June 10, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of RABAVERT RABIES VACC W-DILUENTS to the Defense Logistics Agency (DLA). The $2,095.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 20, 2025 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,461.05, is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a rabies vaccine. The contract is a Firm Fixed Price Delivery Order with a performance period ending on January 22, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of RABAVERT rabies vaccine with diluents. The award, valued at $10,479.00, is a Firm Fixed Price Delivery Order contract issued by the Defense Logistics Agency, a defense agency. The contract has an ultimate completion date of June 13, 2025 and does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $40,239.36, is a firm fixed price delivery order, and has an ultimate completion date of March 11, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...